BONEBRIDGE – ACTIVE BONE CONDUCTION HEARING AID

Georgescu, Madalina; Budu, V.; Vrinceanu, Daniela; Cernea, Magdalena

doi:10.1515/sbeef-2017-0020

Abstract

For individuals with conductive or mixed hearing loss, a bone conduction system can be a very effective treatment option. These systems bypass the outer and middle ear to send sound vibrations directly to the cochlea. This offers a natural sound quality for recipients. BONEBRIDGE is the first active, intact skin hearing implant for bone conduction stimulation, ideal for moderate to severe conduction hearing losses. It is a semi-implantable system, consisting of a surgical implantable part and an externally worn audio processor. Biomaterials used proved their safety, with very low rate of medical complications (skin infections, chronic suppurative otitis media, biofilm formation or extrusion).

References

[1] WHO report, May 2017.
Search in Google Scholar Back to article
[2] Tisch M. [Implantable Hearing Devices]. Laryngorhinootologie. (2017) Apr; 96(S01): S84-S102. 10.1055/s-0042-11877528499296
Search in Google Scholar Back to article
[3] Bravo-Torres, S.; Der-Mussa, C.; Fuentes-Lopez, E. “Active transcutaneous bone conduction implant: audiological results in paediatric patients with bilateral microtia associated with external auditory canal atresia.” International journal of audiology, 1-8, 2017. 10.1080/14992027.2017.137013728857620
Search in Google Scholar Back to article
[4] Zhao, SQ, Ren, R, Han, DM, Li, Y, Ma, XB, Wang, DN, Li, YL. (2017) “The implantation of Bonebridge in bilateral congenital malformation of external and middle ear.” Zhonghua ErBi Yan Hou Tou Jing Wai Ke Za Zhi,. 52(7): p. 512-516.
Search in Google Scholar Back to article
[5] Sprinzl GM., Wolf-Magele A. (2016). “The Bonebridge Bone Conduction Hearing Implant: Indication criteria, surgery and a systematic review of the literature.” Clin Otolaryngol. 41(2):131-43. doi: 10.1111/coa.12484.
Open DOI Search in Google Scholar Back to article
[6] Gavilan J, Adunka O, Agrawal S, Atlas M, Baumgartner WD, Brill S, Bruce I, Buchman C, Caversaccio M, De Bodt MT, Dillon M, Godey B, Green K, Gstoettner W, Hagen R, Hagr A, Han D, Kameswaran M, Karltorp E, Kompis M, Kuzovkov V, Lassaletta L, Li Y, Lorens A, Martin J, Manoj M, Mertens G, Mlynski R, Mueller J, O'Driscoll M, Parnes L, Pulibalathingal S, Radeloff A, Raine CH, Rajan G, Rajeswaran R, Schmutzhard J, Skarzynski H, Skarzynski P, Sprinzl G, Staecker H, Stephan K, Sugarova S, Tavora , Usami S, Yanov Y, Zernotti M, Zorowka P, de Heyning PV. “Quality standards for bone conduction implants.” Acta Oto-Laryngologica.135 (12); 1277-1285, 2015. 10.3109/00016489.2015.106790426223816
Search in Google Scholar Back to article
[7] Georgescu M., Vrinceanu D., Radulescu L., Tusaliu M., Martu C., Curutiu C., Hussien MD., Budu V. “Microbial biofilms and implantable hearing aids.” Romanian Biotechnological Letters Vol. 22, No. 4, 12681-12686, 2017, ISSN 1224-5984.
Search in Google Scholar Back to article
[8] Pirlich M, Dietz A, Meuret S, Hofer M.(2017) “Implantable Bone Conduction and Active Middle Ear Devices.” Laryngorhinootologie. Feb; 96(2): 120-129.
Search in Google Scholar Back to article
[9] Volkenstein S., Thomas J.P., Dazert S. (2016) “Bone Conduction and Active Middle Ear Implants.” Laryngorhinootologie. 95(5):352-63. doi: 10.1055/s-0042-104946.
Open DOI Search in Google Scholar Back to article
[10] Bianchin G., Bonali M., Russo M. & Tribi L. “Active bone conduction system: outcomes with the Bonebridge transcutaneous device.” ORL J Otorhinolaryngol Relat Spec, 77(1), 17-26,2015. doi: 10.1159/000371425.
Open DOI Search in Google Scholar Back to article
[11] Tsang W. S., Yu J. K., Bhatia K. S., Wong T. K. & Tong M. C. “The Bonebridge semiimplantable bone conduction hearing device: experience in an Asian patient.” J Laryngol Otol, 127(12), 1214-1221, 2013. doi: 10.1017/s0022215113002144.
Open DOI Search in Google Scholar Back to article
[12] Sprinzl G., Lenarz T., Ernst A., Hagen R., Wolf-Magele A., Mojallal H., Wolframm M. D. “First European multicenter results with a new transcutaneous bone conduction hearing implant system: short-term safety and efficacy.” Otol Neurotol, 34(6), 1076-1083, 2013. doi: 10.1097/MAO.0b013e31828bb541.
Open DOI Search in Google Scholar Back to article

BONEBRIDGE – ACTIVE BONE CONDUCTION HEARING AID

Abstract

Paradigm

My account